Contracting Out Gives Laboratories An In With Diagnostics Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers and laboratories have until September to begin complying with FDA's analyte specific reagent policy, clarified in 2007 guidelines. But some labs, particularly those specializing in molecular diagnostics, are scrambling to fill what could be a gap in needed supplies